| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,618 |
5,353 |
$205K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,230 |
2,843 |
$186K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,574 |
2,055 |
$101K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
451 |
409 |
$54K |
| 0240U |
|
386 |
353 |
$33K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
563 |
497 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
255 |
227 |
$24K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
831 |
741 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
599 |
283 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
115 |
105 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,745 |
1,388 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
151 |
146 |
$5K |
| 87631 |
|
38 |
36 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
389 |
326 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,228 |
1,777 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
202 |
171 |
$3K |
| 80053 |
Comprehensive metabolic panel |
760 |
638 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
92 |
92 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
27 |
25 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
48 |
$702.90 |
| 81003 |
|
540 |
440 |
$609.22 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
88 |
57 |
$393.70 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
84 |
66 |
$328.87 |
| 87081 |
|
30 |
28 |
$148.37 |